Invea Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
IPO
- (Cancelled)
- Latest Deal Amount
-
$35.2M
- Investors
-
1
Invea Therapeutics General Information
Description
Invea Therapeutics Inc is a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases, or Immune-Mediated Inflammatory Diseases. Their pipeline includes INVA8001 which is designed as an oral, small molecule, highly selective and potent inhibitor of chymase, a key mediator of mast cells driving inflammation, epithelial barrier damage and fibrosis and INVA8003 is a de-novo small molecule multi-inflammasome inhibitor that has shown strong inhibition of a key pro-inflammatory marker for several IMIDs in early preclinical testing.
Contact Information
Website
www.inveatx.comCorporate Office
- 2614 Boston Post Road
- Suite 33AR
- Guilford, CT 06437
- United States
Corporate Office
- 2614 Boston Post Road
- Suite 33AR
- Guilford, CT 06437
- United States
Invea Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. IPO | 06-Mar-2026 | $35.2M | Cancelled | Generating Revenue | ||
| 4. Early Stage VC (Series A1) | 08-Apr-2025 | Completed | Clinical Trials - Phase 1 | |||
| 3. IPO | 29-Mar-2024 | Cancelled | Clinical Trials - Phase 1 | |||
| 2. Early Stage VC (Series A) | 22-Apr-2022 | $5.25M | $9.5M | Completed | Clinical Trials - Phase 1 | |
| 1. Early Stage VC (Series A) | $4.24M | $4.24M | Completed | Pre-Clinical Trials |
Invea Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Invea Therapeutics Comparisons
Industry
Financing
Details
Invea Therapeutics Competitors (2)
One of Invea Therapeutics’s 2 competitors is Verismo Therapeutics, a Venture Capital-Backed company based in Philadelphia, PA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Verismo Therapeutics | Venture Capital-Backed | Philadelphia, PA | ||||
| Cabaletta Bio | Formerly VC-backed | Philadelphia, PA |
Invea Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Invea Therapeutics Patents
Invea Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026035766-A1 | Pharmaceutical formulations and methods of use thereof | Pending | 05-Aug-2024 | ||
| US-20250206714-A1 | Compositions and methods for treatment of inflammatory diseases | Pending | 21-Nov-2022 | ||
| JP-2025531886-A | Compositions and methods for treating inflammatory diseases | Pending | 12-Sep-2022 | ||
| EP-4587029-A1 | Compositions and methods for treatment of inflammatory diseases | Pending | 12-Sep-2022 | ||
| WO-2024059085-A1 | Compositions and methods for treatment of inflammatory diseases | Inactive | 12-Sep-2022 | C07D401/06 |
Invea Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Invea Therapeutics Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Connecticut Innovations | Venture Capital | Minority |
Invea Therapeutics FAQs
-
When was Invea Therapeutics founded?
Invea Therapeutics was founded in 2021.
-
Where is Invea Therapeutics headquartered?
Invea Therapeutics is headquartered in Guilford, CT.
-
What is the size of Invea Therapeutics?
Invea Therapeutics has 3 total employees.
-
What industry is Invea Therapeutics in?
Invea Therapeutics’s primary industry is Drug Discovery.
-
Is Invea Therapeutics a private or public company?
Invea Therapeutics is a Private company.
-
What is the current valuation of Invea Therapeutics?
The current valuation of Invea Therapeutics is .
-
What is Invea Therapeutics’s current revenue?
The current revenue for Invea Therapeutics is .
-
How much funding has Invea Therapeutics raised over time?
Invea Therapeutics has raised $9.8M.
-
Who are Invea Therapeutics’s investors?
Connecticut Innovations has invested in Invea Therapeutics.
-
Who are Invea Therapeutics’s competitors?
Verismo Therapeutics and Cabaletta Bio are competitors of Invea Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
